CH EPL (R5)
1.0.0-ballot - ballot Switzerland flag

This page is part of the CH EPL (R5) (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Datasource Authorised Medicinal Product
... 4 Dataexport FOPH Spezialitätenliste
... 5 Cuprior
... 6 Entocort
... 7 Estalis
... 8 Keytruda
... 9 Paxlovid
... 10 Triogen
... 11 Profiles
... 12 Extensions
... 13 Terminology
... 14 Changelog
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Full Limitation Text
.... 15.15 CH - EPL Product Price
.... 15.16 CH - EPL Regulated Authorization Limitation
.... 15.17 CH - EPL Reimbursement SL
.... 15.18 CH - SMC Authorized Dose Form
.... 15.19 CH - Authorisation Type
.... 15.20 CH - Medicinal Product Name Type
.... 15.21 CH - Other Characteristics Type
.... 15.22 CH EPL - Gamme
.... 15.23 CH EPL - Limitation Status
.... 15.24 CH EPL - Listing Status
.... 15.25 CH EPL - Other Characteristics Packaged Item
.... 15.26 CH EPL - Price Type
.... 15.27 CH EPL - Product Type
.... 15.28 CH EPL - Reimbursement Status
.... 15.29 CH EPL - Type of Price Change
.... 15.30 CH SMC - Attached Document Type
.... 15.31 CH SMC - Authorisation Category
.... 15.32 CH SMC - Authorisation Status
.... 15.33 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.34 CH SMC - Ingredient Role
.... 15.35 CH SMC - Legal Status of Supply
.... 15.36 CH SMC - Marketing Status
.... 15.37 CH SMC - Pediatric Use Indicator
.... 15.38 CH SMC - Special Precautions for Storage
.... 15.39 CH SMC - Substance
.... 15.40 CH SMC - TherapeuticProductcode
.... 15.41 CH SMC- Additional Monitoring Indicator
.... 15.42 EDQM - Combination Packaging
.... 15.43 EDQM - Combined Pharmaceutical Dose Form
.... 15.44 EDQM - Combined Term
.... 15.45 EDQM - Packaging
.... 15.46 EDQM - Pharmaceutical Dose Form
.... 15.47 EDQM - Route Of Administration
.... 15.48 EDQM - Unit of Presentation
.... 15.49 EMA - Domain
.... 15.50 EMA - Intended Effect
.... 15.51 EMA - Shelf Life Type
.... 15.52 CH - Authorisation Type
.... 15.53 CH - Medicinal Product Name Type
.... 15.54 CH - Other Characteristics Type
.... 15.55 CH EPL - Gamme
.... 15.56 CH EPL - Limitation Status
.... 15.57 CH EPL - Listing Status
.... 15.58 CH EPL - Other Characteristics Packaged Item
.... 15.59 CH EPL - Price Type
.... 15.60 CH EPL - Product Type
.... 15.61 CH EPL - Reimbursement Status
.... 15.62 CH EPL - Type of Price Change
.... 15.63 CH SMC - Additional Monitoring Indicator
.... 15.64 CH SMC - Attached Document Type
.... 15.65 CH SMC - Authorisation Category
.... 15.66 CH SMC - Authorisation Status
.... 15.67 CH SMC - Ingredient Role
.... 15.68 CH SMC - Legal Status of Supply
.... 15.69 CH SMC - Marketing Status
.... 15.70 CH SMC - Pediatric Use Indicator
.... 15.71 CH SMC - Special Precautions for Storage
.... 15.72 CH SMC - Substance
.... 15.73 CH SMC - TherapeuticProductcode
.... 15.74 EDQM - Standard Terms
.... 15.75 EMA - Domain
.... 15.76 EMA - Intended Effect
.... 15.77 EMA - Shelf Life Type
.... 15.78 FOPH Dossier Number
.... 15.79 GLN Identifier
.... 15.80 Global Trade Item Number
.... 15.81 LOC Identifier
.... 15.82 5204201
.... 15.83 52042011
.... 15.84 5470402
.... 15.85 54704089
.... 15.86 66231001
.... 15.87 6623101
.... 15.88 67431001
.... 15.89 6743101
.... 15.90 67719001
.... 15.91 6771901
.... 15.92 68793001
.... 15.93 6879301
.... 15.94 CH-52042011
.... 15.95 CH-54704089
.... 15.96 CH-66231001
.... 15.97 CH-67431001
.... 15.98 CH-68291001
.... 15.99 CH-68793001
.... 15.100 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.101 CUPRIOR Filmtabl 150 mg 72 Stk (Bundle)
.... 15.102 Cuprior, Filmtabletten Fachinformation
.... 15.103 Cuprior, Filmtabletten Patienteninformation
.... 15.104 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.105 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.106 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.107 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.108 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.109 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.110 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.111 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.112 Indication 10009900
.... 15.113 Indication 10019927
.... 15.114 Indication 10021782
.... 15.115 Indication 10027400
.... 15.116 Indication 10028881
.... 15.117 Indication 10030247
.... 15.118 Indication 10031285
.... 15.119 Indication 10043971
.... 15.120 Indication 10061091
.... 15.121 Indication 10075566
.... 15.122 Indication 10084529
.... 15.123 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.124 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.125 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.126 Limitation 254837009
.... 15.127 Limitation 79886009
.... 15.128 Limitation 840539006
.... 15.129 MI Budesonidum-2.3mg-Tablet
.... 15.130 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.131 MI Nirmatrelvir-150mg-Tablet
.... 15.132 MI Pembrolizumab-100mg-Vial
.... 15.133 MI Ritonavirum-100mg-Tablet
.... 15.134 MI Solvent
.... 15.135 MI Trientinum-150mg-Tablet
.... 15.136 MI Trientinum-250mg-Capsule
.... 15.137 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.138 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.139 Paxlovid, Filmtabletten Patienteninformation
.... 15.140 PhP Budesonidum-Suspension
.... 15.141 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.142 PhP Pembrolizumab-100mg-Vial
.... 15.143 PhP Trientinum-150mg-Tablet
.... 15.144 PhP Trientinum-150mg-Tablet
.... 15.145 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.146 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.147 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.148 Reimbursement SL 17418
.... 15.149 Reimbursement SL 17973
.... 15.150 Reimbursement SL 20416
.... 15.151 Reimbursement SL 21070
.... 15.152 Reimbursement SL 21208
.... 15.153 Reimbursement SL 21529
.... 15.154 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.155 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.156 Triogen, Kapseln Fachinformation
.... 15.157 Triogen, Kapseln Patienteninformation